Allspring Global Investments Holdings LLC Has $46.78 Million Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Allspring Global Investments Holdings LLC raised its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 336,449 shares of the medical research company's stock after acquiring an additional 7,390 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.11% of Agilent Technologies worth $46,777,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Synovus Financial Corp raised its position in shares of Agilent Technologies by 2.3% in the 1st quarter. Synovus Financial Corp now owns 6,751 shares of the medical research company's stock valued at $895,000 after purchasing an additional 153 shares in the last quarter. Blair William & Co. IL increased its position in shares of Agilent Technologies by 7.3% in the 1st quarter. Blair William & Co. IL now owns 28,606 shares of the medical research company's stock worth $3,785,000 after purchasing an additional 1,957 shares during the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Agilent Technologies by 52.1% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company's stock valued at $309,000 after purchasing an additional 799 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Agilent Technologies by 1.1% during the first quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company's stock worth $3,246,209,000 after purchasing an additional 261,435 shares during the last quarter. Finally, Zions Bancorporation N.A. grew its stake in Agilent Technologies by 10.8% in the first quarter. Zions Bancorporation N.A. now owns 2,880 shares of the medical research company's stock worth $381,000 after purchasing an additional 281 shares in the last quarter. 87.42% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have commented on A. Citigroup increased their target price on Agilent Technologies from $130.00 to $145.00 and gave the stock a "neutral" rating in a report on Wednesday, February 28th. UBS Group boosted their target price on shares of Agilent Technologies from $130.00 to $155.00 and gave the company a "neutral" rating in a research note on Wednesday, February 28th. Oppenheimer increased their target price on shares of Agilent Technologies from $67.00 to $90.00 and gave the stock an "outperform" rating in a report on Tuesday, March 26th. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $135.00 and gave the company an "underweight" rating in a report on Wednesday. Finally, Evercore ISI increased their price objective on shares of Agilent Technologies from $132.00 to $145.00 and gave the stock an "in-line" rating in a research note on Thursday, April 4th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $141.29.

Insider Transactions at Agilent Technologies

In other news, Director Heidi Fields sold 1,658 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the transaction, the director now directly owns 54,976 shares of the company's stock, valued at $7,935,235.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, Director Heidi Fields sold 1,658 shares of the company's stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $144.34, for a total transaction of $239,315.72. Following the transaction, the director now directly owns 54,976 shares of the company's stock, valued at $7,935,235.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Rodney Gonsalves sold 4,828 shares of the business's stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $149.00, for a total transaction of $719,372.00. Following the transaction, the vice president now directly owns 21,329 shares in the company, valued at $3,178,021. The disclosure for this sale can be found here. Insiders have sold 61,610 shares of company stock valued at $9,220,333 over the last three months. Company insiders own 0.33% of the company's stock.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock traded down $4.27 during trading on Friday, hitting $140.73. The stock had a trading volume of 1,119,167 shares, compared to its average volume of 1,581,589. The business has a fifty day moving average of $140.87 and a two-hundred day moving average of $128.62. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $151.58. The firm has a market cap of $41.24 billion, a P/E ratio of 33.42, a PEG ratio of 4.36 and a beta of 1.11. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.68 and a quick ratio of 2.04.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.07. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. Agilent Technologies's revenue was down 5.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.37 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.51 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd will be issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Monday, April 1st. Agilent Technologies's payout ratio is 22.38%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.